P19 EXTERNAL VALIDATION OF THREE EXISTING EARLY MYELOMA RELAPSE SCORES (BY EBMT, CIBMTR, AND GIMEMA) IN A SINGLE CENTER SHOWS MAJOR DIFFERENCES

Slični predmeti

• Allogeneic Hematopoietic Cell Transplantation for Relapsed/ Refractory Hodgkin Lymphoma: A Multicenter Real-World Experience
  od: Derya Koyun, i dr.
  Izdano: (2026-06-01)
• Eltrombopag for the Treatment of Poor Graft Function Following Haematopoietic Cell Transplantation: Real-Life Data
  od: Ekin Kırcalı, i dr.
  Izdano: (2023-01-01)
• Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience
  od: Pinar Ataca Atilla, i dr.
  Izdano: (2018-01-01)
• PB2213: RETROSPECTIVE ANALYSIS OF 45 UNSELECTED PATIENTS WITH HISTIOCYTOSIS CONFIRMS PROGNOSTIC RELEVANCE OF ORGAN INVOLVEMENT: SINGLE‐CENTER EXPERIENCE
  od: Hulya Yilmaz, i dr.
  Izdano: (2023-08-01)
• Highlighting the Prognostic Importance of Measurable Residual Disease Among Acute Myeloid Leukemia Risk Factors
  od: Zehra Narlı Özdemir, i dr.
  Izdano: (2021-06-01)